Study Details
Full Title
A Phase 1, Open-Label, Safety and Immunogenicity Trial of Boost-2867, an IgG-Fc-RBD Fusion Protein Next Generation SARS-CoV-2 Booster Vaccine, Via Intranasal and Intramuscular Routes in Previously Vaccinated Adults
Principal Investigator
Emmanuel
Walter
Protocol Number
PRO00120019
Phase
I
Enrollment Status
Open to Enrollment